Vizilite Plus with T-Blue

ViziLite Plus with TBlue^TM is anoral lesion identification and marking system that is used as anadjunct to the conventional head and neck examination. It is comprisedof a chemiluminescent light source (ViziLite) to improve theidentification of lesions and a blue phenothiazine dye to mark thoselesions identified by ViziLite. ViziLitePlus with TBlue^TM is designed to be used in a patient population at increased risk for oral cancer.

Lumenoscopy^{TM -}  Examination of the Oral Cavity with ViziLite

In clinical trials involving 13,000 female patients, abnormalsquamous epithelium in the cervical complex appears distinctlywhite after washing the cervix with a dilute acetic acid solution andviewed under chemiluminescent light (Speculite®). Similarly, examination of the oral cavity under chemiluminescent light(ViziLite) after rinsing with a dilute acetic acid solution, abnormalsquamous epithelium tissue will appear distinctly white. Lumenoscopy^TMhas demonstrated in numerous studies to improve the ability tovisualize mucosal lesions and initially identify clinically suspiciouslesions. 

ViziLite Lumenoscopy^TM

TBlue^TM Oral Lesion Marking System

TBlue^TM is a patented,pharmaceutical-grade toluidine blue-based metachromatic dye.  It isused to further evaluate and closely monitor changes inViziLite-identified lesions.  It has been proposed that living cellswill differentially accumulate toluidine blue based on parametersrelated to metabolic activity.  TBlue^TM , packagedin an easy to use 3-swab system, provides the deep blue staining thatallows ViziLite-identified lesions to be seen clearly under normallight. 

Ships within 2-5 days